Apogee Therapeutics (APGE) Change in Cash (2022 - 2026)
Apogee Therapeutics (APGE) reported Change in Cash of $320.2 million for Q1 2026, up 1018.33% year-over-year from $28.6 million in Q1 2025, and up 1254.97% on a QoQ basis from $23.6 million in Q4 2025.
Apogee Therapeutics (APGE) has 5 years of Change in Cash data on file, last reported at $320.2 million in Q1 2026.
- Quarterly Change in Cash rose 1018.33% year-over-year to $320.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $344.6 million (up 191.03% YoY) and the FY2025 annual result came in at -$10.5 million, down 144.88% from the prior year.
- Change in Cash rose to $320.2 million in Q1 2026 per APGE's latest filing, from $23.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $367.1 million in Q1 2024 and bottomed at -$188.5 million in Q3 2024.
- The 5-year median for Change in Cash is -$2.4 million (2022), against an average of $29.8 million.
- Peak annual rise in Change in Cash reached 3577.7% in 2024, while the deepest fall reached 995.41% in 2024.
- Tracing APGE's Change in Cash over 5 years: stood at $149.3 million in 2022, then sank by 146.65% to -$69.7 million in 2023, then surged by 133.03% to $23.0 million in 2024, then increased by 2.72% to $23.6 million in 2025, then soared by 1254.97% to $320.2 million in 2026.
- Per Business Quant, the three latest APGE Change in Cash figures stand at $320.2 million (Q1 2026), $23.6 million (Q4 2025), and -$16.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - | 320.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 320.25 Mn |
| Dec 31, 2025 | 23.64 Mn |
| Sep 30, 2025 | -16.57 Mn |
| Jun 30, 2025 | 17.28 Mn |
| Mar 31, 2025 | -34.87 Mn |
| Dec 31, 2024 | 23.01 Mn |
| Sep 30, 2024 | -188.52 Mn |
| Jun 30, 2024 | -178.16 Mn |
| Mar 31, 2024 | 367.14 Mn |
| Dec 31, 2023 | -69.66 Mn |
| Sep 30, 2023 | 63.20 Mn |
| Jun 30, 2023 | -16.26 Mn |
| Mar 31, 2023 | -10.56 Mn |
| Dec 31, 2022 | 149.31 Mn |
| Sep 30, 2022 | -2.39 Mn |